Cost variation analysis of parenteral antibiotics in Indian pharmaceutical market
Keywords:Parenteral antibiotics, Pharmacoeconomics, Cost variation, Indian market
Background: The objective of the present study was to analyse price differences between parenteral antibiotics available in a tertiary care teaching hospital.
Methods: The study was done in the Department of Pharmacology of S. D. M. College of Medical Sciences, Dharwad, Karnataka. Latest volume of current index of medical specialties or Indian Drug Review was used to analyze the prices of parenteral antibiotics.
Results: Overall, prices of 17 single drug antibiotics available in 37 strengths marketed and 8 fixed-dose combinations available in 16 strength marketed were analyzed. It was observed that the maximum cost variation among the single ingredient parenteral antibiotic was with cefpirome 1000 mg. The price difference being Rs. 283 and the cost variation being 90.7%. The minimum price variation was seen with Ampicillin 100 mg of Rs. 4.3 and the cost variation being 40.2%. Additionally the highest price difference was also seen teicoplanin 400 mg i.e., Rs. 610 and its cost variation being 68.5%. Among the fixed-dose combination (FDC’s) the maximum price variation was observed in the combination of cefoperazone+sulbactum 1000+1000 of Rs. 340. Whereas the cost variation of the same was 212.5 %. The minimum price variation among the FDC’s was of the combination of ceftriaxone 250 mg + tazobactum 31.25 mg Rs. 3.3 and its cost variation being 7.9 %.
Conclusions: Pharmacoeconomics facets must be taken into deliberation by healthcare practitioners while prescribing antibiotics to the patients for infectious disease treatment. This will assist compliance, reduce antibiotic resistance and treatment failure.
Rataboli PV, Garg A. Confusing brand names: Nightmare of medical profession. J Postgrad Med 2005;51:13-6.
Chawan VS, Badwane SV, Gawand KV, Chhaya MU. Analysis of price variation amongst different formulations of anxiolytic drugs available in Indian market. Int J Res Med Sci. 2016;4:2398-401.
Das SC, Mandal M, Mandal SC. A critical study on availability and price variation between different brands: Impact on access to medicines. Indian J Pharm Sci. 2007;69:160-3.
Kolasani BP, Divyashanthi CM. Pharmacoeconomics analysis of drugs used for peptic ulcer in India. Int J Basic Clin Pharmacol 2016;5:1672-7.
Nagaraja PS, Vedavathi H. Cost analysis study of price variation among the various brands of antiepilepticus available in India. Int J Basic Clin Pharmacol. 2017;6:422-6.
Kolasani BP, Malathi DC, Ponnaluri RR. Variation of cost among anti-cancer drugs available in Indian market. J Clin Diagn Res. 2016;10:FC17-20.
Date AP, Mahajan HM, Dashputra AV, Bhosale RR. Study of variation in price of various antidiabetic drugs available in Indian market. Int J Basic Clin Pharmacol. 2015;4:36-40.
Karve AV, Paul KB. Economic analysis of oral cephalosporins in the Indian market. Int J Res Med Sci. 2016;4:4143-9.
Brunton LB, Lazo JS, Parker KL. Penicillins, cephalosporins and other beta lactam antibiotics. Goodman and Gilman’s The Pharmacological Basis of Therapeutics. 12th ed. New York: McGraw-Hill; 2011: 741-748.
Meropol NJ, Schulman KA. Cost of cancer care: Issues and implications. J Clin Oncol. 2007;25:180-6.
Karve AV, Chattar KB. Cost analysis study of oral antihypertensive agents available in Indian market. Int J Basic Clin Pharmacol. 2014;3:479-84.
Jadhav NB, Bhosale MS, Adhar CV. Cost analysis study of oral antidiabetic drugs available in Indian market. Int J Med Res Health Sci. 2014;2:63-9.
Panchal SS, Pandit PR, Phatak AM, Lohi KM. Cost analysis of antiretroviral agents available in India. Int J Basic Clin Pharmacol. 2015;4:479-82.
Shukla AK, Sharma P. Cost variation analysis of antidyslipidemic drugs. Int J Basic Clin Pharmacol. 2016;5:1850-5.
Shankar PR, Subish P, Mishra P, Lalit M. Ambiguous pricing of Nepalese medicines. J Inst Med. 2006;28:35-8.
Patel D, Thiyagu R, Surulivelrajan M, Patel H, Pandey S. Price variability among the oral antibiotics available in a South Indian tertiary care hospital. J Clin Diagn Res. 2009;3:1871-5.
Rataboli PV, Dang A. Antimicrobial price variation: conundrum of medical profession!. J Postgrad Med. 2007;53:72-4.
Shareef J, Mateti UV, James JB, Rao D, Stanly SM, Samaga L. Analysis of price variation among parenteral antibiotics available in a tertiary care teaching hospital. J Patient Saf Infect Control. 2017;5:89-93.